China SXT Pharmaceuticals Inc (SXTC)’s financial ratios: A comprehensive overview

In other words, the price has increased by $0.0000 from its previous closing price. On the day, 60713 shares were traded.

Ratios:

We take a closer look at SXTC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.31 and its Current Ratio is at 1.35. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.03.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SXTC now has a Market Capitalization of 955.75k and an Enterprise Value of -12.66M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.49 while its Price-to-Book (P/B) ratio in mrq is 1.31. Its current Enterprise Value per Revenue stands at -6.42 whereas that against EBITDA is 2.36.

Stock Price History:

The Beta on a monthly basis for SXTC is 1.01, which has changed by -75.56% over the last 52 weeks, in comparison to a change of 29.57% over the same period for the S&P500. Over the past 52 weeks, SXTC has reached a high of $9.38, while it has fallen to a 52-week low of $1.56. The 50-Day Moving Average of the stock is 1.8906, while the 200-Day Moving Average is calculated to be 3.0164.

Shares Statistics:

According to the various share statistics, SXTC traded on average about 1.09M shares per day over the past 3-months and 210.14k shares per day over the past 10 days. A total of 11.43M shares are outstanding, with a floating share count of 0.55M. Insiders hold about 3.13% of the company’s shares, while institutions hold 1.62% stake in the company. Shares short for SXTC as of Mar 15, 2024 were 5.54k with a Short Ratio of 0.01, compared to 33.83k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.98% and a Short% of Float of 1.30%.

Most Popular

[the_ad id="945"]